Under the EU MDR, technical documentation must demonstrate lifecycle safety, performance, and compliance through GSPR, risk management, clinical evaluation, PMS/PMCF, labeling, and a restructured evidence chain rather than legacy MDD materials alone.
Answer: EU MDR medical device technical documentation requirements cover the product description, design and manufacturing information, GSPR compliance, risk management, performance verification, biocompatibility or electrical safety, software and cybersecurity, clinical evaluation, PMS/PMCF, labels and instructions for use, and the Declaration of Conformity. Technical documentation is not a one-time certification package; it is an evidence system proving safety, performance, and compliance control throughout the product lifecycle. Companies should not simply reuse legacy MDD documentation. They should restructure the evidence chain according to MDR requirements and ensure consistency among product claims, risk controls, clinical evidence, and post-market plans.
Published: 2026-07-06 09:00 | Updated: 2026-07-06 09:00
Source note: Compiled from the Aimeili registration practice question bank, the international medical device registration knowledge base, and public regulatory information. Specific projects should be based on the latest requirements of the target country regulatory authority and the product data foundation.
This FAQ addresses international medical device registration, document preparation, compliance pathways, and post-market maintenance, highlighting the questions companies should prioritize in actual projects.
Content Structure
- Key Summary
- Applicable Scenarios and Core Questions
- Registration Judgment Logic
- Materials and Evidence
- Common Errors
- Company Preparation Checklist
- Aimeili Viewpoint
- Common Follow-Up Questions
- Continue Reading
- Applicability Boundary
Key Summary
EU MDR medical device technical documentation requirements cover product description, design and manufacturing information, GSPR compliance, risk management, performance verification, biocompatibility or electrical safety, software and cybersecurity, clinical evaluation, PMS/PMCF, labels and instructions for use, and the Declaration of Conformity. Technical documentation is not a one-time certification package; it is an evidence system proving safety, performance, and compliance control throughout the product lifecycle. Companies should not simply reuse legacy MDD documentation. They should restructure the evidence chain according to MDR requirements and ensure consistency among product claims, risk controls, clinical evidence, and post-market plans.
Applicable Scenarios and Core Questions
Companies searching for EU MDR technical documentation requirements are usually preparing for CE certification or MDR transition, but they are unsure how deep the technical documentation should be. The MDR technical file is not a simple document package; it is a complete evidence system demonstrating product safety, performance, clinical evaluation, risk control, and post-market surveillance capabilities.
Registration Judgment Logic
Companies should first confirm the product classification, applicable MDR annexes, notified body pathway, clinical evaluation requirements, General Safety and Performance Requirements, and post-market surveillance plan. Different risk classes require different depths of technical documentation, clinical evidence, and quality management system review.
Core Materials and Evidence
Common content includes product description, intended use, design and manufacturing information, GSPR compliance matrix, risk management, performance verification, biocompatibility or electrical safety documentation, software and cybersecurity documentation, clinical evaluation, PMS, PMCF, labels and instructions for use, and the Declaration of Conformity.
Common Errors
- GSPR matrix is completed without supporting evidence.
- Clinical evaluation does not match product claims.
- PMS/PMCF is treated as a formality.
- Model coverage is unclear.
- Legacy MDD documentation is not restructured according to MDR requirements.
Company Preparation Checklist
Companies should first establish an MDR technical file index, evidence matrix, and gap list, then check design, risk, verification, clinical, labeling, and post-market surveillance documents item by item.
Aimeili Viewpoint
Aimeili recommends treating the MDR technical file as a long-term maintenance system, not one-time certification material. The technical file, quality management system, clinical evaluation, and post-market data need continuous updates.
Common Follow-Up Questions
Can legacy MDD documentation be used directly for MDR?
Usually not as is. It needs to be restructured according to MDR structure, GSPR, clinical evaluation, and post-market surveillance requirements.
Where is the MDR technical file most likely to be questioned?
Common focus areas include clinical evidence, the GSPR evidence chain, risk management, PMS/PMCF, and consistency of labeling and claims.
Continue Reading
Previous: Malaysia MDA Medical Device Registration Document Checklist?
Next: What Procedures Are Required for China Medical Device Exports to Indonesia?
Related Recommendations:
- How to Prepare the Indonesia Medical Device Registration Document Checklist?
- How to Complete the Singapore HSA Medical Device Registration Process?
- What Documents Are Required for Vietnam Medical Device Import Registration?
- How to Select a Local Agent for Middle East Medical Device Registration?
- How Do UDI and Product Classification Codes Affect Overseas Registration?
- How to Choose the First Batch of Target Countries for Medical Device Market Entry?
- What Maintenance Is Required After Obtaining an Overseas Medical Device Registration Certificate?
- How to Conduct a Gap Assessment for Overseas Medical Device Registration Technical Documentation?
- What Procedures Are Required for China Medical Device Exports to Indonesia?
Return to FAQ Center | Contact Aimeili
Content Review and Applicability Boundaries
Content author: Aimeili Regulatory Editorial Department
Professional review: Aimeili Medical Device International Registration Project Team
Source principles: Priority is given to official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as auxiliary judgment.
Applicability boundary: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of target country regulatory agencies, testing conclusions, or legal opinions.
Need a registration pathway assessment?
Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.
Contact AIMEILI